Amar Remedies Ltd
Amar Remedies Limited, incorporated in India, listed on the Bombay Stock Exchange, and National Stock Exchange Limited, the company is engaged in Manufacuring and Trading of Ayurvedic Products and FMCG.
- Market Cap ₹ Cr.
- Current Price ₹ 6.07
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 101
- Dividend Yield 0.00 %
- ROCE 18.7 %
- ROE 20.6 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.06 times its book value
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | |
|---|---|---|---|---|
| 369 | 491 | 597 | 684 | |
| 322 | 422 | 514 | 571 | |
| Operating Profit | 47 | 69 | 83 | 113 |
| OPM % | 13% | 14% | 14% | 17% |
| 2 | 1 | 1 | -3 | |
| Interest | 12 | 21 | 27 | 40 |
| Depreciation | 7 | 10 | 11 | 13 |
| Profit before tax | 30 | 39 | 46 | 58 |
| Tax % | 11% | 15% | 15% | 21% |
| 27 | 33 | 39 | 45 | |
| EPS in Rs | 10.18 | 12.58 | 14.96 | 17.39 |
| Dividend Payout % | 10% | 8% | 7% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 23% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 23% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| Last Year: | 21% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | |
|---|---|---|---|---|
| Equity Capital | 26 | 26 | 26 | 26 |
| Reserves | 126 | 155 | 192 | 237 |
| 88 | 124 | 249 | 365 | |
| 48 | 60 | 26 | 57 | |
| Total Liabilities | 288 | 366 | 493 | 686 |
| 108 | 115 | 124 | 165 | |
| CWIP | 0 | 1 | 14 | 4 |
| Investments | 0 | 0 | 0 | 0 |
| 180 | 250 | 355 | 517 | |
| Total Assets | 288 | 366 | 493 | 686 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | |
|---|---|---|---|---|
| 2 | -11 | -2 | -31 | |
| -31 | -19 | -47 | -49 | |
| 29 | 33 | 57 | 77 | |
| Net Cash Flow | 1 | 3 | 8 | -3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | |
|---|---|---|---|---|
| Debtor Days | 81 | 83 | 87 | 100 |
| Inventory Days | 138 | 106 | 117 | 164 |
| Days Payable | 14 | 11 | 11 | 12 |
| Cash Conversion Cycle | 205 | 178 | 194 | 252 |
| Working Capital Days | 126 | 136 | 181 | 234 |
| ROCE % | 22% | 19% | 19% |